or Try an Advanced Search...

    Technical Analysis for CING - Cingulate Inc.

    Grade Last Price % Change Price Change
    F 0.34 7.50% 0.02
    CING closed up 7.5 percent on Monday, July 1, 2024, on 14.04 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CING trend table...
    Date Alert Name Type % Chg
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Calm After Storm Range Contraction 0.00%
    Wide Range Bar Range Expansion 0.00%
    Doji - Bullish? Reversal 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Below Lower BB Weakness 0.00%
    Older End-of-Day Signals for CING ...

       Recent Intraday Alerts

    Alert Time
    Down 10% about 6 hours ago
    Down 5% about 6 hours ago
    Down 3% about 6 hours ago
    Reversal New Lows Entry about 6 hours ago
    Bearish 180 Entry about 6 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CING Chart by TradingView
    Basic chart:

    Profile

    Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), Cingulate is identifying and evaluating additional therapeutic areas where PTR technology may be employed to develop future product candidates.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Neuroscience Pharmaceutical Products Attention Deficit Hyperactivity Disorder Amphetamine Methylphenidate Adhd Educational Psychology

    Is CING a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds
    Jun 25 Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event
    Jun 25 Cingulate Achieves Key Manufacturing Milestone in the Development of its ADHD Drug CTx-1301 in Preparation for FDA Marketing Clearance
    May 8 Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
    Apr 29 Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
    Apr 16 Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024
    Mar 19 Cingulate to Participate in Benzinga All Live Access Event
    Mar 6 Cingulate to Attend DCAT Week 2024 in New York City
    Feb 13 Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
    Feb 5 Peering Into Cingulate's Recent Short Interest
    See more CING news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.2
    52 Week Low 0.284
    Average Volume 415,490
    200-Day Moving Average 4.19
    50-Day Moving Average 0.76
    20-Day Moving Average 0.62
    10-Day Moving Average 0.54
    Average True Range 0.10
    RSI (14) 23.66
    ADX 22.48
    +DI 6.77
    -DI 29.67
    Chandelier Exit (Long, 3 ATRs) 0.44
    Chandelier Exit (Short, 3 ATRs) 0.60
    Upper Bollinger Bands 0.85
    Lower Bollinger Band 0.40
    Percent B (%b) -0.12
    BandWidth 71.94
    MACD Line -0.09
    MACD Signal Line -0.07
    MACD Histogram -0.0243
    Fundamentals Value
    Market Cap 971.86 Thousand
    Num Shares 2.83 Million
    EPS -31.20
    Price-to-Earnings (P/E) Ratio -0.01
    Price-to-Sales 0.00
    Price-to-Book 105.12
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.74
    Resistance 3 (R3) 0.77 0.66 0.68
    Resistance 2 (R2) 0.66 0.56 0.65 0.65
    Resistance 1 (R1) 0.50 0.49 0.45 0.48 0.63
    Pivot Point 0.39 0.39 0.37 0.38 0.39
    Support 1 (S1) 0.24 0.29 0.18 0.21 0.06
    Support 2 (S2) 0.13 0.23 0.11 0.03
    Support 3 (S3) -0.03 0.13 0.01
    Support 4 (S4) -0.06